A Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies

For full description, see www.clinicaltrials.gov.

Abstracts/Posters/Presentations:

• D. Bodenmiller, S. Jalal, J. Turchi, J. Wu, Z. Yu, L. Einhorn. A phase I study of Amrubicin (AMR) and Cyclophosphamide in patients with advanced solid organ malignancies: Correlative analysis of a trial from the Hoosier Oncology Group LUN07-130. Accepted as abstract (Abstract # e17517) at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL.
• S. Jalal, J. Bufill, M. Guarino , N. Somaiah , K. Koneru, J. McClean, R.Sanborn, J. Wu, Z. Yu, L. Einhorn. A phase I study of Amrubicin (AMR) and Cyclophosphamide in patients with advanced solid organ malignancies: A trial from the Hoosier Oncology Group LUN07-130. Accepted as a Poster Presentation at the General Poster Session at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL. J Clin Oncol 29: 2011 (suppl; abstr 7082)
• Shadia Ibrahim Jalal, Nasser H. Hanna, Robin Zon, Gregory A. Masters, Hossein Borghaei, Karuna Koneru, Sunil S. Badve, Nagendra K Prasad, Neeta Somaiah, Jingwei Wu, Zhangsheng Yu, Lawrence H. Einhorn. Final results of a phase I study of amrubicin and cyclophosphamide in patients with advanced solid organ malignancies: HOG LUN 07-130. Presented at the general poster session, lung cancer – non-small cell local-regional/ small cell/other thoracic cancers at the ASCO Annual Meeting, May 31, 2014, Chicago IL. J Clin Oncol 32:5s, 2014 (suppl; abstr 7594). See abstract.

Manuscripts/Articles:

• Jalal SI, Hanna N, Zon R, Masters GA, Borghaei H, Koneru K, Badve S, Prasad N, Somaiah N, Wu J, Yu Z, Einhorn L. Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130. Am J Clin Oncol. 2017 Aug;40(4):329-335. doi: 10.1097/COC.0000000000000160. See abstract.